Sun Pharmaceutical Industries Ltd. has announced the appointment of Jayashree Satagopan as its new Chief Financial Officer (CFO), effective upon the retirement of C.S. Muralidharan. This strategic leadership transition marks a new chapter in Sun Pharma’s financial stewardship.
With over 20 years of experience in finance and corporate strategy, Satagopan previously held the role of President – Corporate and CFO at Coromandel International Limited, where she played a pivotal role in strengthening financial frameworks and driving business growth. Her leadership excellence has been recognized through several industry accolades, including the prestigious ‘Woman CFO of the Year’ award at the CII CFO Excellence Awards 2021.
In her new role, Satagopan is expected to bring strategic financial acumen and global perspective, further enhancing Sun Pharma’s market position. Her appointment aligns with the company’s broader goal of accelerating its growth trajectory in the global pharmaceutical landscape through robust financial leadership and strategic foresight.